Title

A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.

Document Type

Journal Article

Publication Date

9-1-2018

Journal

Pediatric blood & cancer

Volume

65

Issue

9

DOI

10.1002/pbc.27217

Keywords

Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Hypersensitivity; Female; Gastrointestinal Diseases; Glioma; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Neoplasms; Progression-Free Survival; Taxoids; Treatment Failure

Peer Reviewed

1

This document is currently not available here.

Share

COinS